"AVS secures $36m to support US launch of Pulse IVL device" was originally created and published by Medical Device Network, a ...

POWER PAD II IDE trial will evaluate safety and efficacy of the Pulse IVL™ system in patients with severely calcified peripheral arterial disease AVS received an investigational device exemption ...

AVS (Amplitude Vascular Systems) is a company creating a new treatment option for PIVL: its balloon-based platform, called the PULSE IVL System, is able to shatter calcium with pressure waves in ...

AVS’s novel balloon-based platform, the PULSE™ IVL System, shatters calcium with pressure waves in frequent bursts and expands calcified arteries, all with a single device. "We are proud to support ...

Amplitude Vascular Systems ( AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its novel PULSE IVL™ platform, announced today ...